OptiNose (OPTN) Stock Chart & Stock Price History → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Free OPTN Stock Alerts $0.95 -0.08 (-7.43%) (As of 03:52 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability OptiNose Stock Price Performance5 Day Performance+2.78%1 Month Performance-41.50%3 Month Performance-32.85%6 Month Performance-10.05%Year-To-Date Performance-26.09%1 Year Performance-49.01% Receive OPTN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter Email Address Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. OPTN Stock Chart for Tuesday, April, 23, 2024 OPTN Chart by TradingView OptiNose Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/22/2024$0.89$1.03+15.19%$1.05$0.861.26 million shs$116.03 million04/19/2024$0.93$0.89-3.61%$0.97$0.89653,099 shs$100.73 million04/18/2024$1.02$0.93-9.05%$1.03$0.92548,193 shs$104.51 million04/17/2024$1.09$1.02-6.42%$1.13$1.01461,327 shs$114.90 million04/16/2024$1.19$1.09-8.40%$1.19$1.09362,600 shs$122.79 million04/15/2024$1.22$1.19-2.46%$1.22$1.16508,955 shs$134.06 million Get the Latest News and Ratings for OPTN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter. 04/12/2024$1.24$1.22-1.61%$1.25$1.16796,543 shs$137.43 million04/11/2024$1.25$1.24-0.80%$1.26$1.22615,835 shs$139.69 million04/10/2024$1.23$1.25+1.63%$1.25$1.20439,385 shs$140.82 million04/09/2024$1.33$1.23-7.52%$1.36$1.22350,815 shs$138.56 million04/08/2024$1.32$1.33+0.76%$1.35$1.30284,915 shs$149.82 million04/05/2024$1.37$1.32-3.65%$1.41$1.30377,720 shs$148.70 million04/04/2024$1.38$1.37-0.72%$1.40$1.34438,945 shs$154.33 million04/03/2024$1.41$1.38-2.13%$1.43$1.38233,597 shs$155.46 million04/02/2024$1.44$1.41-2.08%$1.47$1.40187,855 shs$158.84 million04/01/2024$1.46$1.44-1.37%$1.49$1.42492,460 shs$162.22 million03/29/2024$1.46$1.46$1.50$1.41399,834 shs$164.47 million03/28/2024$1.48$1.46-1.35%$1.50$1.41399,574 shs$164.47 million03/27/2024$1.48$1.48$1.49$1.43400,436 shs$166.72 million03/26/2024$1.50$1.48-1.33%$1.56$1.46443,253 shs$166.72 million03/25/2024$1.63$1.50-7.98%$1.64$1.46995,181 shs$168.98 million03/22/2024$1.66$1.63-1.81%$1.68$1.57770,338 shs$183.62 million03/21/2024$1.72$1.66-3.21%$1.72$1.62431,559 shs$187.00 million03/20/2024$1.72$1.72-0.29%$1.76$1.621.55 million shs$193.20 million03/19/2024$1.94$1.72-11.11%$1.98$1.691.49 million shs$193.76 million03/18/2024$1.88$1.94+2.93%$2.10$1.764.25 million shs$217.98 million03/15/2024$1.90$1.87-1.58%$1.93$1.724.35 million shs$210.66 million03/14/2024$1.93$1.90-1.55%$1.92$1.85349,553 shs$214.04 million03/13/2024$1.90$1.93+1.85%$1.94$1.85504,346 shs$217.41 million03/12/2024$1.86$1.90+1.88%$1.91$1.83363,152 shs$213.47 million03/11/2024$1.68$1.86+10.71%$1.89$1.70797,249 shs$208.90 million03/08/2024$1.72$1.68-2.33%$1.77$1.64452,941 shs$188.68 million03/07/2024$1.75$1.72-1.71%$1.78$1.62384,834 shs$193.17 million03/06/2024$1.73$1.75+1.45%$1.79$1.72310,082 shs$196.54 million03/05/2024$1.73$1.73-0.29%$1.77$1.66316,748 shs$193.74 million03/04/2024$1.91$1.73-9.42%$1.94$1.67653,931 shs$194.30 million03/01/2024$1.78$1.91+7.30%$1.91$1.77471,365 shs$214.51 million02/29/2024$1.82$1.78-1.93%$1.86$1.74378,099 shs$199.91 million02/28/2024$1.69$1.82+7.40%$1.85$1.70969,326 shs$203.84 million02/27/2024$1.65$1.69+2.42%$1.75$1.60553,186 shs$189.80 millionThe A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself.02/26/2024$1.56$1.65+5.77%$1.71$1.58554,329 shs$185.32 million02/23/2024$1.47$1.56+6.12%$1.69$1.48911,845 shs$175.20 million02/22/2024$1.34$1.47+9.70%$1.51$1.351.06 million shs$165.10 million02/21/2024$1.36$1.34-1.47%$1.39$1.33193,879 shs$150.50 million02/20/2024$1.37$1.36-0.37%$1.42$1.36208,956 shs$152.74 million02/19/2024$1.37$1.37$1.38$1.33184,000 shs$153.30 million02/16/2024$1.35$1.37+1.11%$1.38$1.33182,536 shs$153.30 million02/15/2024$1.35$1.35$1.38$1.30351,714 shs$151.62 million02/14/2024$1.27$1.35+6.30%$1.36$1.27241,830 shs$151.62 million02/13/2024$1.36$1.27-6.62%$1.35$1.27388,457 shs$142.63 million02/12/2024$1.34$1.36+1.49%$1.39$1.32304,993 shs$152.74 million02/09/2024$1.26$1.34+6.35%$1.40$1.24544,203 shs$150.50 million02/08/2024$1.26$1.26$1.29$1.24199,614 shs$141.51 million02/07/2024$1.28$1.26-1.56%$1.31$1.25243,779 shs$141.51 million02/06/2024$1.22$1.28+4.92%$1.34$1.21309,945 shs$143.76 million02/05/2024$1.21$1.22+0.83%$1.26$1.22209,708 shs$137.02 million02/02/2024$1.26$1.21-3.97%$1.26$1.20307,151 shs$135.90 million02/01/2024$1.26$1.26$1.30$1.24210,491 shs$141.51 million01/31/2024$1.35$1.26-6.67%$1.34$1.26323,280 shs$141.51 million01/30/2024$1.42$1.35-4.93%$1.42$1.30363,364 shs$151.62 million01/29/2024$1.44$1.42-1.39%$1.46$1.39318,139 shs$159.48 million01/26/2024$1.46$1.44-1.37%$1.48$1.43213,181 shs$161.73 million01/25/2024$1.46$1.46$1.49$1.40235,061 shs$163.97 million01/24/2024$1.42$1.46+2.82%$1.50$1.43351,238 shs$163.97 million01/23/2024$1.39$1.42+2.16%$1.43$1.37171,168 shs$159.48 million01/22/2024$1.36$1.39+2.21%$1.41$1.32268,180 shs$156.11 million Related Companies: Repare Therapeutics Stock Price Chart Nuvectis Pharma Stock Price Chart CytomX Therapeutics Stock Price Chart Citius Pharmaceuticals Stock Price Chart Coya Therapeutics Stock Price Chart Eliem Therapeutics Stock Price Chart Karyopharm Therapeutics Stock Price Chart FibroGen Stock Price Chart Societal CDMO Stock Price Chart Immunic Stock Price Chart Receive OPTN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OPTN) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIncredible Opportunity to Retire FAST!Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiNose, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.